Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF)
USD 0.65
(0.0%)
USD 0.65
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 59 Million | 71.37 Million | 99.72 Million | 18.15 Million | 76.39 Million | 76.79 Million |
| Net Income | 69.18 Million | 82.67 Million | 77.94 Million | 69.95 Million | 71.37 Million | 74.17 Million |
| Depreciation & Amortization | 10.56 Million | 9.66 Million | 8.97 Million | 10.07 Million | 10.17 Million | 3.87 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -34.32 Million | -41.84 Million | 7.69 Million | -54.41 Million | -23.85 Million | -2.85 Million |
| Other non-cash items | 13.57 Million | 20.88 Million | 5.1 Million | -7.45 Million | 62.9 Million | 12.2 Million |
| Investing Cash Flow | -138.08 Million | 41.04 Million | -34.65 Million | 61.6 Million | 101.01 Million | -79.03 Million |
| Investments in PPE | -21.86 Million | -4.92 Million | -3 Million | -1.66 Million | -2.18 Million | -6.79 Million |
| Acquisitions | 7169.68 | -400.92 Thousand | -1.64 Million | 3869.05 | 13.86 Thousand | 347.79 Thousand |
| Investment purchases | -144.14 Million | - | -30 Million | -0.05 | - | -72.58 Million |
| Sales/Maturities of investments | - | 46.37 Million | - | 63.26 Million | 103.17 Million | - |
| Other Investing Activities | -116.21 Million | - | -1.00 | - | 803.95 Million | - |
| Financing Cash Flow | -47.65 Million | -67.94 Million | -35.22 Million | -33.53 Million | -112.22 Million | -22.44 Million |
| Debt repayment | -220 Thousand | -55.42 Thousand | -28.33 Thousand | -158.37 Thousand | -21.3 Thousand | -82.12 Thousand |
| Dividends payments | -35.36 Million | -56.79 Million | -25.76 Million | -24.83 Million | -102.06 Million | -20.31 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.99 Million | -11.09 Million | -9.43 Million | -8.54 Million | -4.27 Million | -2.21 Million |
| Accounts receivables | 63.01 Million | -55.57 Million | 2.97 Million | -28.31 Million | -17.18 Million | -2.66 Million |
| Accounts payables | 2.19 Million | 19.74 Million | -3.6 Million | -4.34 Million | 3.89 Million | 1.94 Million |
| Inventory | -543.59 Million | -6.01 Million | 8.32 Million | -21.76 Million | -10.56 Million | -2.14 Million |
| Other working capital | 509.27 Million | -1.00 | - | -1.00 | 1.00 | - |
| Cash at beginning of period | 254.86 Million | 212.9 Million | 183.91 Million | 135.61 Million | 70.22 Million | 95.99 Million |
| Cash at end of period | 128 Million | 254.86 Million | 212.9 Million | 183.91 Million | 135.61 Million | 70.22 Million |
| Capital Expenditure | -21.86 Million | -4.92 Million | -3 Million | -1.66 Million | -2.18 Million | -6.79 Million |
| Effect of forex changes on cash | -1.28 Million | -16.77 Million | 1.47 Million | 10.84 Million | -0.17 | - |
| Net cash flow / Change in cash | -126.85 Million | 41.96 Million | 28.98 Million | 48.29 Million | 65.39 Million | -25.77 Million |
| Free Cash Flow | 37.13 Million | 66.44 Million | 96.71 Million | 16.49 Million | 74.21 Million | 69.99 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.07 Million | 14.04 Million | 69.18 Million | 17.56 Million | 17.51 Million | 16.97 Million |
| Depreciation & Amortization | 2.74 Million | 2.74 Million | 10.56 Million | 2.7 Million | 2.63 Million | 2.49 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -34.32 Million | -3.29 Million | -3.28 Million | - |
| Other non-cash items | -36.27 Million | -36.19 Million | 13.57 Million | -20.42 Million | -20.29 Million | 13.35 Million |
| Investing Cash Flow | 86.46 Million | 86.28 Million | -138.08 Million | -46.58 Million | -46.45 Million | -22.39 Million |
| Investments in PPE | -718.2 Thousand | -716.69 Thousand | -21.86 Million | -950.24 Thousand | -947.54 Thousand | -448.31 Thousand |
| Acquisitions | - | - | 7169.68 | 3200.75 | - | 3954.67 |
| Investment purchases | - | - | -144.14 Million | -96.98 Million | - | -46.98 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 87.18 Million | 87 Million | -116.21 Million | -45.63 Million | -45.5 Million | -21.95 Million |
| Financing Cash Flow | -20.5 Million | -20.46 Million | -47.65 Million | -3.14 Million | -3.14 Million | -20.6 Million |
| Debt repayment | - | - | -220 Thousand | -10.75 Thousand | - | -17.34 Thousand |
| Dividends payments | -17.68 Million | -17.65 Million | -35.36 Million | - | - | -17.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.81 Million | -2.81 Million | -3.99 Million | -3.14 Million | -3.14 Million | -2.98 Million |
| Accounts receivables | - | - | 63.01 Million | 31.51 Million | 31.42 Million | - |
| Accounts payables | - | - | 2.19 Million | - | - | - |
| Inventory | - | - | -543.59 Million | -34.8 Million | -34.7 Million | - |
| Other working capital | - | - | 509.27 Million | - | - | - |
| Cash at beginning of period | - | - | 254.86 Million | 312.3 Million | - | 254.86 Million |
| Cash at end of period | 46.2 Million | 46.11 Million | 128 Million | 128 Million | -52.8 Million | 312.3 Million |
| Capital Expenditure | -718.2 Thousand | -716.69 Thousand | -21.86 Million | -950.24 Thousand | -947.54 Thousand | -448.31 Thousand |
| Effect of forex changes on cash | -298.69 Thousand | -298.06 Thousand | -1.28 Million | 216.36 Thousand | 215.75 Thousand | -297.34 Thousand |
| Net cash flow / Change in cash | 46.2 Million | 46.11 Million | -126.85 Million | -184.3 Million | -52.8 Million | 57.44 Million |
| Free Cash Flow | -20.17 Million | -20.13 Million | 37.13 Million | -4.38 Million | -4.37 Million | 32.38 Million |
5236
TTMZF
EVKG
BAJAJHCARE
SBFM
7164